Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study

MLA

Rui Wang, et al. “Advanced Nanoparticles That Can Target Therapy and Reverse Drug Resistance May Be the Dawn of Leukemia Treatment: A Bibliometrics Study.” Frontiers in Bioengineering and Biotechnology, vol. 10, Oct. 2022. EBSCOhost, https://doi.org/10.3389/fbioe.2022.1027868.

APA

Rui Wang, Changming Zhao, Shuxia Jiang, Zhaohua Zhang, Chunmei Ban, Guiping Zheng, Yan Hou, Bingjin Jin, Yannan Shi, Xin Wu, & Qiangqiang Zhao. (2022). Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study. Frontiers in Bioengineering and Biotechnology, 10. https://doi.org/10.3389/fbioe.2022.1027868

Chicago

Rui Wang, Changming Zhao, Shuxia Jiang, Zhaohua Zhang, Chunmei Ban, Guiping Zheng, Yan Hou, et al. 2022. “Advanced Nanoparticles That Can Target Therapy and Reverse Drug Resistance May Be the Dawn of Leukemia Treatment: A Bibliometrics Study.” Frontiers in Bioengineering and Biotechnology 10 (October). doi:10.3389/fbioe.2022.1027868.